Johnson & Johnson (NYSE: JNJ) is having a strong start to Thursday's trading session. The drugmaker and medical technology giant's shares were up 5.74% on heavy volume at 10:36 a.m. ET Thursday morning.

What's powering this rally? Ahead of the opening bell, J&J released 2023 second-quarter earnings that exceeded Wall Street's expectations on both top and bottom lines.  

The second quarter of 2023 was a successful one for J&J, as the company reported strong growth in its pharmaceutical and medtech segments. Here are some of the key takeaways from the report:

Continue reading

Source Fool.com